本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Enliven Treateutics

50.24
+1.122.28%
盤後49.92-0.3200-0.64%19:30 EDT
成交量:196.35萬
成交額:9,902.42萬
市值:36.81億
市盈率:-29.99
高:51.83
開:49.58
低:49.32
收:49.12
52周最高:62.32
52周最低:14.79
股本:7,327.08萬
流通股本:6,172.59萬
量比:1.53
換手率:3.18%
股息:- -
股息率:- -
每股收益(TTM):-1.6753
每股收益(LYR):-1.8300
淨資產收益率:-15.31%
總資產收益率:-11.00%
市淨率:4.11
市盈率(LYR):-27.45

資料載入中...

2024/03/14

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/14

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/14

重要事件披露

Form 8-K - Current report
2024/03/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/16

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities